Their research technique of measuring electrical brain activity using an electroencephalogram (EEG) in these brain regions also
predicted mild cognitive impairment (MCI), a condition that is likely to develop into Alzheimer's, with 80 per cent accuracy.
Not exact matches
Ongoing studies at Uppsala University in Sweden have shown that the chemical agent dubbed Pittsburgh Compound - B, or PIB, is a highly accurate marker of plaque buildup and that its abundance in the brain can
predict whether patients with
mild cognitive impairment will develop Alzheimer's — and when that decline will likely start.
A further analysis showed that 10 of these proteins could
predict whether individuals with
mild cognitive impairment would develop Alzheimer's within a year.
Brain imaging using radioactive dye can detect early evidence of Alzheimer's disease that may
predict future
cognitive decline among adults with
mild or no
cognitive impairment, according to a 36 - month follow - up study led by Duke Medicine.
OBJECTIVE To use functional MRI (fMRI) to investigate whether hippocampal activation during a memory task can
predict cognitive decline in individuals with
mild cognitive impairment (MCI).
Studies carried out by a team of scientists concluded that the new blood tests were able to
predict, with an 87 percent accuracy rate, whether patients suffering from MCI (
Mild Cognitive Impairment) would develop Alzheimer's disease within a year.